share_log

BMO Capital Maintains Market Perform on Ingevity, Raises Price Target to $55

BMO Capital Maintains Market Perform on Ingevity, Raises Price Target to $55

BMO Capital维持Ingevity的市场表现,将目标股价上调至55美元
Benzinga ·  05/08 11:22

BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Market Perform and raises the price target from $50 to $55.

BMO Capital分析师约翰·麦克纳尔蒂维持Ingevity(纽约证券交易所代码:NGVT)的市场表现,并将目标股价从50美元上调至55美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发